BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4978254)

  • 1. [Prevention of sensitization of Rh-negative mothers following birth of a Rh-positive child and blood group serological control of mothers during pregnancy].
    Schneider J; Preisler O
    Hippokrates; 1968 Mar; 39(5):165-70. PubMed ID: 4978254
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with prophylactic serological examinations of expectant mothers].
    Bösenberg M
    Dtsch Med Wochenschr; 1966 Dec; 91(49):2202-5. PubMed ID: 4959062
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention and treatment of Rh. isoimmunization. Results].
    Martínez M; Lozano G; Flores F; Fernández P; Garrido G
    Acta Obstet Ginecol Hisp Lusit; 1971 Mar; 19(2):149-57. PubMed ID: 4996734
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of gamma globulin (anti-Rh IgG) in the prevention of Rh isoimmunization].
    Rosemblit J; Rosales T; de Lima GR; Leonhardt HG; Fonseca A; Martins H
    Matern Infanc (Sao Paulo); 1971; 30(1):41-4. PubMed ID: 5002691
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selective Rh prevention in pregnancy].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1983; 45(3):261-74. PubMed ID: 6421025
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prospects of the clinical use of immunosuppressive agents in control of materno-fetal Rh isoimmunization and in attempted prevention. (Theoretical presuppositions and preliminary clinical experiences)].
    Vecchietti G; Onnis A
    Minerva Ginecol; 1970 May; 22(9):459-62. PubMed ID: 4995415
    [No Abstract]   [Full Text] [Related]  

  • 7. [Incidence of irregular antibodies found in patients and in pregnancy tests].
    Busch H; Rothe B von E; Hochweller E
    Munch Med Wochenschr; 1970 Feb; 112(8):341-51. PubMed ID: 4997704
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary clinical experiences with immunosuppressive agents in prenatal treatment of Rh isoimmunization].
    Viozzi A; Gasparini G; Cagliari P
    Minerva Ginecol; 1970 May; 22(9):462-3. PubMed ID: 4995416
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing maternal sensitization to Rho antigen.
    Alter AA; Haut IH
    N Y State J Med; 1971 Oct; 71(19):2326-7. PubMed ID: 4999308
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of Rh hemolytic disease of the newborn.
    Jennings ER; Dibbern HH; Hodell FH; Monroe CH; Peckham NH; Sullivan JF; Pollack W
    Calif Med; 1969 Feb; 110(2):130-3. PubMed ID: 4181977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of Rh-isoimmunization in connection with spontaneous abortion and interruption of pregnancy].
    Kiss D; Szöke B
    Zentralbl Gynakol; 1974 Mar; 96(13):398-401. PubMed ID: 4208562
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitization of Rh-negative daughters by their Rh-positive mothers.
    Taylor JF
    N Engl J Med; 1967 Mar; 276(10):547-51. PubMed ID: 4960066
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-D-prevention within the scope of a regional work-community].
    Luboldt W; Lohmeyer H; Schmolling E; Hoize J; Neumann H
    Med Klin; 1970 May; 65(22):1082-8. PubMed ID: 5000118
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of Rho(D) sensitization in Rh-negative primiparas by use of anti-rhesus immunoglobulin].
    Verbitskiĭ MSh; Viazov OE; Bashlaĭ AG; Morgulis NB; Babicheva MM
    Vopr Okhr Materin Det; 1971 Nov; 16(11):46-50. PubMed ID: 4110764
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical aspects in the prevention of antibody formation with anti-D-immunoglobulin].
    Frey P; Hinselmann M; Hindemann P
    Gynaecologia; 1969; 167(5):280-4. PubMed ID: 4184764
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological aspects of the prevention of hemolytic disease of the newborn].
    Antonian AK
    Zh Eksp Klin Med; 1973; 13(6):44-9. PubMed ID: 4215267
    [No Abstract]   [Full Text] [Related]  

  • 18. [Systematic immunization in pregnancy].
    Simonetti N
    Minerva Ginecol; 1972 Feb; 24(2):98-9. PubMed ID: 4211684
    [No Abstract]   [Full Text] [Related]  

  • 19. [Status of the prevention of the hemolytic disease of the newborn with gamma globulin in Switzerland].
    de Muralt G; Stampfli K
    Gynaecologia; 1969; 167(5):285-8. PubMed ID: 4184765
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of Rh sensitization using anti-D immunoglobulin. (An 8 year study)].
    Spoljarić I; Majnarić M
    Jugosl Ginekol Opstet; 1978; 18(5-6):417-22. PubMed ID: 119891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.